Journals / Turkish Journal of Endocrinology and Metabolism / 2020 / Cilt: 24 - Sayı: 4

Giant Malignant Pheochromocytoma: A Unique Case Report from Turkey

Dev Malign Feokromositoma Vakası

Pages
356–360
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During an examination for hematuria, a large mass was detected incidentally in the right adrenal gland of the patient.This mass was diagnosed as pheochromocytoma and provedto be one of the largest pheochromocytomas reported sofar; hence, its notification has been considered significantfor the medical and research professionals across the world.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Catecholamine-secreting tumors are rare neoplasms thatoccur in less than 0.2% of hypertensive patients.
📊
Key Findings & Data:In thisreport, we present the case of a 38-year-old man who hada 29x18x12 cm giant malignant pheochromocytoma.
💡
Conclusion & Impact:During an examination for hematuria, a large mass was detected incidentally in the right adrenal gland of the patient.This mass was diagnosed as pheochromocytoma and provedto be one of the largest pheochromocytomas reported sofar; hence, its notification has been considered significantfor the medical and research professionals across the world.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Catecholamine-secreting tumors are rare neoplasms thatoccur in less than 0.2% of hypertensive patients. While pheochromocytomas are rare neoplasms in the adrenal gland,giant pheochromocytomas are much less common. In thisreport, we present the case of a 38-year-old man who hada 29x18x12 cm giant malignant pheochromocytoma. During an examination for hematuria, a large mass was detected incidentally in the right adrenal gland of the patient.This mass was diagnosed as pheochromocytoma and provedto be one of the largest pheochromocytomas reported sofar; hence, its notification has been considered significantfor the medical and research professionals across the world.

Özet

Katekolamin salgılayan tümörler, hipertansiyonu olan hastaların yüzde 0,2’sinden daha azında görülen nadir neoplazilerdir. Feokromositomalar adrenal bezde görülen nadir neoplazilerken, dev feokromositomalar çok daha nadir görülmektedir. Bu vaka bildiriminde 38 yaşında 29x18x12 cm boyutlarında dev malign feokromositoma tespit edilen bir erkek hasta tanımlanmıştır. Hasta hematüri nedeni ile tetkik edilirken sağ adrenal bezinde insidental olarak kitle tespit edilmiştir. Türkiye’de tanımlanmış en büyük feokromositomalardan biri olarak bildiriminin önemli olabileceği düşünülmüştür.

🔖

Cite This Article

GÜNAY, Y. E., COŞKUN, H., TÜFEKÇİ, D., DEMİR, A. S., NUHOĞLU, İ., ÜÇÜNCÜ, Ö., KOÇAK, M. (2022). Giant Malignant Pheochromocytoma: A Unique Case Report from Turkey. Turkish Journal of Endocrinology and Metabolism, Cilt: 24 - Sayı: 4, 356–360. https://ajindex.com/articles/605368

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine (Baltimore). 1991
  2. [Crossref] [PubMed] 2. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001
  3. [Crossref] [PubMed] 3. Neumann HP, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B, Kirste G. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med. 1993
  4. [Crossref] [PubMed] 4. Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev. 1994
  5. [Crossref] [PubMed] 5. Bravo EL. Pheochromocytoma: new concepts and future trends. Kidney Int. 1991
  6. [Crossref] [PubMed] 6. Kudva YC, Young WF, Thompson GB, Grant CS, Van Heerden JA. Adrenal incidentaloma: an important component of the clinical presentation spectrum of benign sporadic adrenal pheochromocytoma. The Endocrinologist. 1999
  7. [Crossref] 7. Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N, Chaffanjon P. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol. 2004
  8. [Crossref] [PubMed] 8. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr
  9. Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014
  10. [Crossref] [PubMed] 9. Pederson LC, Lee JE. Pheochromocytoma. Curr Treat Options Oncol. 2003
  11. [Crossref] [PubMed] 10.Dahia PL. Evolving concepts in pheochromocytoma and paraganglioma. Curr Opin Oncol. 2006
  12. [Crossref] [PubMed] 11. Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002
  13. [Crossref] [PubMed] 12.Korgali E, Dundar G, Gokce G, Kilicli F, Elagoz S, Ayan S, Gultekin EY. Giant malignant pheochromocytoma with palpable rib metastases. Case Rep Urol. 2014
  14. 354687. [Crossref] [PubMed] [PMC] 13.Maharaj R, Parbhu S, Ramcharan W, Baijoo S, Greaves W, Harnanan D, Warner WA. Giant cystic pheochromocytoma with low risk of malignancy: a case report and literature review. Case Rep Oncol